Form 4 for BIIB Biogen
Accepted 2022-12-12 00:00:00 ET · period of report 2022-11-14 · accession 0001127602-22-027348 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-12 | 2022-11-14 | BIIB | Gregory Ginger | EVP, Human Resources | S - Sale | $300.11 | -5,610 | 5,711 | -50% | -$1.68M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | S | D | 5,610 | $300.11 | 5,711.02 | D | — | — | (F2) Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2022. |